Skip to main content
close menu
close menu

Search UK HealthCare

Robert S. DiPaola, MD

Dean, College of Medicine
Dr. Robert DiPaola

Practice Area

  • Genitourinary and Prostate Cancer Team
  • Medical Oncology
Request an Appointment Physician Referral
  • About

    Faculty Rank

    Professor of Medicine

    Degree

    University of Utah, Salt Lake City

    Residency

    Duke University Medical Center, Durham, N.C.

    Fellowship

    Hematology and Oncology, University of Pennsylvania, School of Medicine, Philadelphia

    Certifications and Special Training

    American Board of Internal Medicine

    American Board of Internal Medicine, Medical Oncology

  • Locations

    Medical Oncology

    Multidisciplinary Clinic

    Whitney Hendrickson Building
    UK Markey Cancer Center
    Whitney-Hendrickson Building
    First Floor, Room 134
    800 Rose St.
    Lexington KY 40536
    Fax: 859-257-3757

    A parking lot is located near the Whitney-Hendrickson Building, accessible via Hospital Drive.

    Multidisciplinary Clinic

    Whitney Hendrickson Building
    UK Markey Cancer Center
    Whitney-Hendrickson Building
    First Floor
    800 Rose St.
    Lexington KY 40536

    A parking lot is located near the Whitney-Hendrickson Building, accessible via Hospital Drive.

    Insurance Information

    Insurance policies can vary widely. Please check with your doctor/clinic for specific insurance information before your visit or procedure to avoid unexpected out-of-pocket costs. See list of insurers Arrow Pointing Right

  • Publications

    Publications

    1. Atg7 cooperates with Pten loss to drive prostate cancer growth. Santanam U, Banach-Petrosky W, Abate-Shen C, Shen MM, White E, and DiPaola RS. Genes & Development. 2016 Feb 15;30(4):399-407. PubMed PMID: 26883359; PubMed Central PMCID: PMC4762425.
    2. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. Sweeney CJ, Chen YH, Carducci M, Liu G, Jarrard DF, Eisenberger M, Wong YN, Hahn N, Kohli M, Cooney MM, Dreicer R, Vogelzang NJ, Picus J, Shevrin D, Hussain M, Garcia JA, DiPaola RS. N Engl J Med. 2015 Aug 20; 373(8):737-46. Epub 2015 Aug 5. PMID: 26244877.
    3. Survival following primary androgen deprivation therapy among men with localized prostate cancer. Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS and Yao SL. JAMA. 2008 Jul 9;300(2):173-81. PubMed PMID: 18612114; PubMed Central PMCID: PMC2645653.
    4. Phase I trial of weekly docetaxel with concurrent three-dimensional conformal radiation therapy in the treatment of unfavorable localized adenocarcinoma of the prostate. Kumar P, Perrotti M, Weiss R, Todd M, Goodin S Cummings K and DiPaola RS. J Clin Oncol. 2004 May 15;22(10):1909-15. PubMed PMID: 15143084.
    5. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. DiPaola RS, Zhang H, Lambert GH, Meeker R, Licitra E, et al. N Engl J Med. 1998 Sep 17;339(12):785-91. PubMed PMID: 9738085.
  • Research

    Cancer Center Member

    Research Focus

    Drug Resistance in Cancer Therapy - preclinical studies that support translational clinical trials and investigations into prostate cancer drug resistance.

    Programs

    • Drug Discovery, Delivery and Translational Therapeutics

    College & Department

    • College of Medicine
    • Department of Internal Medicine

    For Referring Physicians

    800 Rose Street
    MN 150
    Lexington, KY 40536-0298
    United States